Hussman Strategic Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 42,000 shares of HRMY stock, worth $1.39 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
42,000
Previous 105,000
60.0%
Holding current value
$1.39 Million
Previous $3.32 Million
65.13%
% of portfolio
0.27%
Previous 0.81%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
296Shares Held
47MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$218 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$192 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$168 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$55.8 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$55.1 Million0.02% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.95B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...